79 Results for "

SSTRs

" in MedChemExpress (MCE) Product Catalog:
Products (79)

79 Results for "SSTRs" in MCE Product Catalog:

Cat. No.: HY-P10741
CAS No.: 2151063-66-8
DOTA-EB-TATE is composed of SST peptide derivative, DOTA-octreotate conjugated a common to an Evans blue analog (EB). DOTA-EB-TATE is a peptide drug conjugate (PDC) improves the pharmacokinetics of SSTR2 analogs and reduces PRRT toxicity. DOTA-EB-TATE can also be used for the synthesis/research of Radionuclide-Drug Conjugates (RDCs) .
loading...
    loading...
Cat. No.: HY-P1139
CAS No.: 485803-62-1
Synonyms: PCFWKTCK
Target:  

GHSR

Research Areas:  

Metabolic Disease

Cortistatin-8 (CST-8; PCFWKTCK), a neuropeptide, is a GHS-R1a antagonist by counteracting the response of ghrelin on gastric acid secretion. Cortistatin-8 can modulate GH release from somatotroph cells. Cortistatin-8 is a synthetic CST-analogue devoid of any binding affinity to SST-R but capable to bind the GHS-R1a. Cortistatin-8 can exert antagonistic effects on ghrelin actions either in vitro or in vivo in animals .
loading...
    loading...
Cat. No.: HY-142701
CAS No.: 2747928-27-2
Target:  

Somatostatin Receptor

Research Areas:  

Neurological Disease

SSTR4 agonist 4 is a somatostatin receptor 4 (SSTR4) agonist. SSTR4 agonist 4 functionally activates SSTR4. SSTR4 agonist 4 has the potential for the research of pain .
loading...
    loading...
Cat. No.: HY-106103A
CAS No.: 99248-33-6
Purity:  99.30%
Synonyms: MK 678 acetate; L 36358 acetate
Seglitide acetate (MK 678; L 36358 acetate) is a potent, orally active somatostatin receptor 2 (SSTR2) agonist, and also a competitive antagonist of SSTR14, SSTR25, and SSTR28. Seglitide acetate has antihypertensive effects and can inhibit plasma glucagon and growth hormone. Seglitide acetate can be used for research on diabetes .
loading...
    loading...
Cat. No.: HY-P0024A
CAS No.: 2126831-23-8
Synonyms: DG3173 TFA; PTR-3173 TFA
Target:  

Somatostatin Receptor

Research Areas:  

Endocrinology Cancer

Veldoreotide (DG3173) TFA a somatostatin analogue, binds to and activate the somatostatin receptors (SSTR) 2, 4, and 5. Veldoreotide TFA inhibits growth hormone (GH) secretion in adenomas compared with Octreotide (HY-P0036). Veldoreotide has the potential to be used as pain modulating agent
loading...
    loading...
Cat. No.: HY-P3124
CAS No.: 182153-96-4
Target:  

Somatostatin Receptor

Research Areas:  

Cancer

BIM-23190, a somatostatin analog, a selective SSTR2 and SSTR5 agonist, exhibits Ki values of 0.34 nM and 11.1 nM for SSTR2 and SSTR5, respectively. BIM-23190 can be used in the study for cancer and acromegaly .
loading...
    loading...
Cat. No.: HY-177493
CAS No.: 3086695-73-7
Target:  

Somatostatin Receptor

Research Areas:  

Others

SSTR3 Agonist-1 (Compound EX 38) is an orally active SSTR3 agonist, with an EC50 of 0.14 nM. SSTR3 Agonist-1 reduces the kidney cystic index. SSTR3 Agonist-1 can be used in the research of autosomal dominant polycystic kidney disease .
loading...
    loading...
Cat. No.: HY-P3618
Cortistatin-29 is a neuropeptide. Cortistatin-29 alleviates neuropathic pain. Cortistatin-29 binds all somatostatin (SS) receptor subtypes with high affinity and shows IC50 values of 2.8 nM, 7.1 nM, 0.2 nM, 3.0 nM, 13.7 nM for SSTR1, SSTR2, SSTR3, SSTR4, SSTR5, respectively. Cortistatin-29 shows anti-fibrotic effects .
loading...
    loading...
Cat. No.: HY-P3294
CAS No.: 778630-77-6
Synonyms: BIM-23A760; TBR-760
Onzigolide (BIM-23A760), a chimeric dopamine-somatostatin compound, shows potent agonist activity at both DA type 2 (D2R) and SST type 2 (SSTR2) receptors .
loading...
    loading...
Cat. No.: HY-P0024
CAS No.: 252845-37-7
Synonyms: DG3173; PTR-3173
Target:  

Somatostatin Receptor

Research Areas:  

Endocrinology Cancer

Veldoreotide (DG3173) a somatostatin analogue, binds to and activate the somatostatin receptors (SSTR) 2, 4, and 5. Veldoreotide inhibits growth hormone (GH) secretion in adenomas compared withOctreotide (HY-P0036). Veldoreotide has the potential to be used as pain modulating agent
loading...
    loading...
Cat. No.: HY-P2434
CAS No.: 846569-60-6
AP102 is a dual SSTR2/SSTR5-specific somatostatin analog (SSA). AP102 is a disulfide-bridged octapeptide SSA containing synthetic iodinated amino acids. AP102 binds with subnanomolar affinity to SSTR2 and SSTR5 (IC50: 0.63 and 0.65 nM, respectively). AP102 does not bind to SSTR1 or SSTR3. AP102 can be used for acromegaly and neuroendocrine tumors research .
loading...
    loading...
Cat. No.: HY-177493A
Target:  

Somatostatin Receptor

Research Areas:  

Metabolic Disease Endocrinology

SSTR3 agonist-1 TFA is a potent, orally active, and selective SSTR3 agnoist (EC50 =0.14 nM). SSTR3 agonist-1 TFA binds to SSTR3 receptor to inhibit cAMP activity. SSTR3 agonist-1 TFA decreases kidney weight and kidney cystic index (KCI) in a mouse model of autosomal dominant polycystic kidney disease (ADPKD). SSTR3 agonist-1 TFA can be used for ADPKD research .
loading...
    loading...
Cat. No.: HY-P4555
CAS No.: 340821-13-8
Target:  

Somatostatin Receptor

Research Areas:  

Neurological Disease

(D-Phe5,Cys6,11,N-Me-D-Trp8)-Somatostatin-14 (5-12) amide (Compound 4) is a somatostatin analog with Kds of 0.61, 11.05, 23.5, 1200 and >1000 nM for SSTR5, SSTR3, SSTR2, SSTR1 and SSTR4, respectively .
loading...
    loading...
Cat. No.: HY-172147
CAS No.: 2761347-44-6
Target:  

Somatostatin Receptor

Research Areas:  

Neurological Disease

SSTR4 agonist 5 (Compound 5) is the orally active agonist for somatostatin receptor 4 (SSTR4) with an EC50 of 0.228 nM. SSTR4 agonist 5 exhibits good stability in human/rat liver microsomes. SSTR4 agonist 5 inhibits mechanical hyperalgesia in rat models .
loading...
    loading...
Cat. No.: HY-160176
CAS No.: 1007836-12-5
Target:  

Somatostatin Receptor

Research Areas:  

Metabolic Disease

SSTR5 antagonist 6 is an orally active somatostatin receptor subtype 5 (SSTR5) antagonist with an IC50 of 24 nM. SSTR5 antagonist 6 can be used in the study of type 2 diabetes .
loading...
    loading...
Cat. No.: HY-142700
CAS No.: 2744188-34-7
Target:  

Somatostatin Receptor

Research Areas:  

Neurological Disease

SSTR4 agonist 3 is a potent agonist of SSTR4. SSTR4 is expressed at relatively high levels in the hippocampus and neocortex, memory and learning regions, and Alzheimer's disease pathology. SSTR4 agonists are potent in rodent models of pain associated with acute and chronic associated anti-peripheral nociceptive and anti-inflammatory activity. SSTR4 agonist 3 has the potential for the research of pain (extracted from patent WO2021233427A1, compound 14) .
loading...
    loading...
Cat. No.: HY-12819
CAS No.: 1235995-16-0
Target:  

Somatostatin Receptor

Research Areas:  

Metabolic Disease Endocrinology

MK-1421 is a potent and selective sstr3 antagonist. MK-1421 regulates insulin secretion by binding to the sstr3. MK-1421 can be used in the research of type 2 diabetes .
loading...
    loading...
Cat. No.: HY-P2545
CAS No.: 59481-23-1
Target:  

Somatostatin Receptor

Research Areas:  

Endocrinology

[Tyr1]-Somatostatin-14 could binds to SSTR2 .
loading...
    loading...
Cat. No.: HY-159825
CAS No.: 2412849-26-2
Target:  

Somatostatin Receptor

Research Areas:  

Endocrinology

Branosotine (compound 1-1) is a potent agonist of somatostatin receptor (SSTR2), with the EC50 of <0.1 nM .
loading...
    loading...
Cat. No.: HY-114133
CAS No.: 161982-62-3
Depreotide is a nove tumor tarcer, can be complexed with technetium-99m ( 99mTc-depreotide) for optimal imaging properties. 99mTc-depreotide somatostain receptor imaging has been playing an important role in medical diagnosis research . Depreotide can be used for the synthesis/research of Radionuclide-Drug Conjugates (RDCs).
loading...
    loading...